Skip to main content

Advertisement

Fig. 2 | EJNMMI Research

Fig. 2

From: Longitudinal tumor hypoxia imaging with [18F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity

Fig. 2

Study baseline data including a pre-treatment mean tumor growth kinetics for each group (day 17 post-inoculation corresponds to day 0 of treatment initiation), b the baseline tumor volume obtained by contouring the volumetric CT data sets (p = 0.202), c the pre-treatment tumor (p = 0.579) and muscle (p = 0.304) FAZA uptake, and d the lack of correlation between tumor FAZA uptake and tumor volume. Each treatment group is composed of 5 mice, each bearing bilateral subcutaneously implanted HT-29 colon cancer xenograft, for a total of 10 tumors per treatment group

Back to article page